跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SD-21
首页
药物
SD-21
SD-21
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Constructing method of aromatizing enzyme disorder rat depression model
申请人: UNIV ZHEJIANG
优先权: 2013
CN
种减毒鼠伤寒沙门氏菌的构建方法及其所得菌株和应用
申请人: 四川农业大学
优先权: 2015
CN
Experimental method for role of IpostC in resistance to intestinal reperfusion injury
申请人: JIA ZHONGZHI
优先权: 2016
CN
Chinese herbal medicine oral tablet for preventing and curing various kinds of lymphoma and preparation method thereof
申请人: LI MINGJIE
优先权: 2019
CN
一种用于油性皮肤护理的神经肽
申请人: 上海小沈生物科技有限公司
优先权: 2021
CN
Experimental method for anticoccidial effectiveness of halofuginone and analogues thereof
申请人: NANJING HUIMU BIOTECHNOLOGY CO LTD
优先权: 2022
CN
Application of circular RNA circLRP6 in preparation of medicine for treating central nervous injury
申请人: UNIV NANTONG
优先权: 2023
CN
Construction method and application of Seneca virus-3A negative labeled virus
申请人: UNIV NANJING AGRICULTURAL
优先权: 2024
CN
Preparation method for constructing rat embryo implantation failure model based on streptococcus agalactiae
申请人: SHENGJING HOSPITAL CHINA MEDICAL UNIV
优先权: 2025
CN
药物
反馈